Cargando…

miR-142-5p promotes renal cell tumorigenesis by targeting TFAP2B

The transcription factor AP-2 β (TFAP2B) serves an important role in kidney development. MicroRNAs (miRNAs) regulate carcinogenic pathways and have gained increasing attention owing to their association with human clear cell renal cell carcinoma (ccRCC) tumorigenesis. However, whether miRNAs could a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Maoshu, Zou, Liangneng, Lu, Fuhua, Ye, Ling, Su, Bin, Yang, Kaichun, Lin, Minghua, Fu, Jianqian, Li, Yongwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583739/
https://www.ncbi.nlm.nih.gov/pubmed/33123240
http://dx.doi.org/10.3892/ol.2020.12187
_version_ 1783599445669052416
author Zhu, Maoshu
Zou, Liangneng
Lu, Fuhua
Ye, Ling
Su, Bin
Yang, Kaichun
Lin, Minghua
Fu, Jianqian
Li, Yongwu
author_facet Zhu, Maoshu
Zou, Liangneng
Lu, Fuhua
Ye, Ling
Su, Bin
Yang, Kaichun
Lin, Minghua
Fu, Jianqian
Li, Yongwu
author_sort Zhu, Maoshu
collection PubMed
description The transcription factor AP-2 β (TFAP2B) serves an important role in kidney development. MicroRNAs (miRNAs) regulate carcinogenic pathways and have gained increasing attention owing to their association with human clear cell renal cell carcinoma (ccRCC) tumorigenesis. However, whether miRNAs could affect renal cell tumorigenesis by regulating TFAP2B expression has not been identified. The aim of this study was to investigate the effects of miRNA on TFAP2B and its potential role in cell growth, invasion and migration. PCR, western blot and dual luciferase reporter assays were performed to analyze the effects of miR-142-5p on TFAP2B. Furthermore, MTT, flow cytometry, wound healing and Transwell migration assays were used to analyze the effect of miR-142-5p on cell proliferation and migration. The results demonstrated that miR-142-5p targeted TFAP2B and downregulated the expression of TFAP2B at the mRNA and protein levels, promoting cell proliferation and migration in two ccRCC cell lines, 786-O and A-498. This phenomenon supported the theory that miR-142-5p may function as an oncogene in ccRCC. The potential clinical significance of miR-142-5p as a biomarker and a therapeutic target provides rationale for further investigation into miR-142-5p-mediated molecular pathways and how these may be associated with ccRCC development.
format Online
Article
Text
id pubmed-7583739
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-75837392020-10-28 miR-142-5p promotes renal cell tumorigenesis by targeting TFAP2B Zhu, Maoshu Zou, Liangneng Lu, Fuhua Ye, Ling Su, Bin Yang, Kaichun Lin, Minghua Fu, Jianqian Li, Yongwu Oncol Lett Articles The transcription factor AP-2 β (TFAP2B) serves an important role in kidney development. MicroRNAs (miRNAs) regulate carcinogenic pathways and have gained increasing attention owing to their association with human clear cell renal cell carcinoma (ccRCC) tumorigenesis. However, whether miRNAs could affect renal cell tumorigenesis by regulating TFAP2B expression has not been identified. The aim of this study was to investigate the effects of miRNA on TFAP2B and its potential role in cell growth, invasion and migration. PCR, western blot and dual luciferase reporter assays were performed to analyze the effects of miR-142-5p on TFAP2B. Furthermore, MTT, flow cytometry, wound healing and Transwell migration assays were used to analyze the effect of miR-142-5p on cell proliferation and migration. The results demonstrated that miR-142-5p targeted TFAP2B and downregulated the expression of TFAP2B at the mRNA and protein levels, promoting cell proliferation and migration in two ccRCC cell lines, 786-O and A-498. This phenomenon supported the theory that miR-142-5p may function as an oncogene in ccRCC. The potential clinical significance of miR-142-5p as a biomarker and a therapeutic target provides rationale for further investigation into miR-142-5p-mediated molecular pathways and how these may be associated with ccRCC development. D.A. Spandidos 2020-12 2020-10-05 /pmc/articles/PMC7583739/ /pubmed/33123240 http://dx.doi.org/10.3892/ol.2020.12187 Text en Copyright: © Zhu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhu, Maoshu
Zou, Liangneng
Lu, Fuhua
Ye, Ling
Su, Bin
Yang, Kaichun
Lin, Minghua
Fu, Jianqian
Li, Yongwu
miR-142-5p promotes renal cell tumorigenesis by targeting TFAP2B
title miR-142-5p promotes renal cell tumorigenesis by targeting TFAP2B
title_full miR-142-5p promotes renal cell tumorigenesis by targeting TFAP2B
title_fullStr miR-142-5p promotes renal cell tumorigenesis by targeting TFAP2B
title_full_unstemmed miR-142-5p promotes renal cell tumorigenesis by targeting TFAP2B
title_short miR-142-5p promotes renal cell tumorigenesis by targeting TFAP2B
title_sort mir-142-5p promotes renal cell tumorigenesis by targeting tfap2b
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583739/
https://www.ncbi.nlm.nih.gov/pubmed/33123240
http://dx.doi.org/10.3892/ol.2020.12187
work_keys_str_mv AT zhumaoshu mir1425ppromotesrenalcelltumorigenesisbytargetingtfap2b
AT zouliangneng mir1425ppromotesrenalcelltumorigenesisbytargetingtfap2b
AT lufuhua mir1425ppromotesrenalcelltumorigenesisbytargetingtfap2b
AT yeling mir1425ppromotesrenalcelltumorigenesisbytargetingtfap2b
AT subin mir1425ppromotesrenalcelltumorigenesisbytargetingtfap2b
AT yangkaichun mir1425ppromotesrenalcelltumorigenesisbytargetingtfap2b
AT linminghua mir1425ppromotesrenalcelltumorigenesisbytargetingtfap2b
AT fujianqian mir1425ppromotesrenalcelltumorigenesisbytargetingtfap2b
AT liyongwu mir1425ppromotesrenalcelltumorigenesisbytargetingtfap2b